Ben Ameur Mehdi Raoudha, Shaaban Khaled A, Rebai Ines Karray, Smaoui Slim, Bejar Samir, Mellouli Lotfi
Laboratory of Prokaryotic Enzymes and Metabolites of the Centre of Biotechnology of Sfax - Tunisia (LEMP-CBS), 3038 Sfax, Tunisia.
Nat Prod Res. 2009;23(12):1095-107. doi: 10.1080/14786410802362352.
Extraction of 25 L fermentation broth of the newly isolated Streptomyces sp. strain TN58 and various separation and purification steps led to the isolation of five bioactive metabolites, namely brevianamide F (C1), reported from a streptomycete for the first time, N(beta)-acetyltryptamine (C2), thiazolidomycin (C3), and two rhamnopyranosides (C4 and C5). These two rhamnopyranosides were produced directly, without precursor addition. The chemical structure of these five active compounds was established on the basis of (1)H, (13)C/APT and 2D NMR spectra, ESI and EI-MS data, and by comparison with data from the literature. According to the biological studies, we show in this work that the compounds C1, C2, C4 and C5 possess antimicrobial activities.
从新分离的链霉菌属菌株TN58的25 L发酵液中进行提取,并经过各种分离和纯化步骤,得到了五种生物活性代谢产物,即首次从链霉菌中报道的短杆菌肽F(C1)、N(β)-乙酰色胺(C2)、噻唑霉素(C3)以及两种鼠李吡喃糖苷(C4和C5)。这两种鼠李吡喃糖苷是直接产生的,无需添加前体。这五种活性化合物的化学结构是根据氢谱(1H)、碳谱/无畸变极化转移增强谱(13C/APT)和二维核磁共振谱、电喷雾电离和电子轰击质谱数据,并与文献数据进行比较而确定的。根据生物学研究,我们在这项工作中表明,化合物C1、C2、C4和C5具有抗菌活性。